欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7521/001
药品名称Eribulin 0.44 mg/ml solution for injection
活性成分
    • Eribulin mesilate 0.44 mg/ml
剂型Solution for injection
上市许可持有人Betapharm Arzneimittel GmbH Kobelweg 95 86156 Augsburg Germany
参考成员国 - 产品名称Germany (DE)
Eribulin beta 0,44 mg/ml Injektionslösung
互认成员国 - 产品名称
    • Romania (RO)
      NEXERELIN 0,44 mg/ml soluție Injectabilă
许可日期2024/03/13
最近更新日期2024/09/03
药物ATC编码
    • L01XX41 eribulin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase